Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | > 100 uM | In vitro inhibitory activity against histone deacetylase (HDAC) isolated from HeLa nuclear extract | ChEMBL. | 14643318 |
IC50 (binding) | > 100 uM | In vitro inhibitory activity against histone deacetylase (HDAC) isolated from HeLa nuclear extract | ChEMBL. | 14643318 |
Inhibition (binding) | = 16 % | In vitro inhibitory activity against histone deacetylase (HDAC) isolated from HeLa nuclear extract at a concentration of 100 uM | ChEMBL. | 14643318 |
Inhibition (binding) | = 16 % | In vitro inhibitory activity against histone deacetylase (HDAC) isolated from HeLa nuclear extract at a concentration of 100 uM | ChEMBL. | 14643318 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.